Bvf Inc Crinetics Pharmaceuticals, Inc. Transaction History

Bvf Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$15.49 - $19.05 $14.6 Million - $18 Million	-942,334 Reduced 25.61%	2,736,613 $50.1 Million
Q2 2022 Aug 15, 2022	BUY	$16.49 - $27.64 $11.1 Million - $18.7 Million	675,068 Added 22.47%	3,678,947 $68.6 Million
Q4 2021 Feb 14, 2022	BUY	$19.35 - $28.41 $39.7 Million - $58.2 Million	2,050,000 Added 214.91%	3,003,879 $85.3 Million
Q3 2021 Nov 15, 2021	BUY	$16.88 - $25.23 $15.7 Million - $23.5 Million	929,599 Added 3828.66%	953,879 $20.1 Million
Q2 2021 Aug 16, 2021	BUY	$15.9 - $21.15 $386,052 - $513,521	24,280 New	24,280 $458,000

241

79.5M

23.3K

44.3K

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.77B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.